2019
DOI: 10.1080/13685538.2019.1670157
|View full text |Cite
|
Sign up to set email alerts
|

LncRNA NR2F2-AS1 positively regulates CDK4 to promote cancer cell proliferation in prostate carcinoma

Abstract: Fu (2020) LncRNA NR2F2-AS1 positively regulates CDK4 to promote cancer cell proliferation in prostate carcinoma,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 30 publications
0
5
0
Order By: Relevance
“…Accumulating literature has unveiled that NR2F2-AS1 is an oncogene in some cancers, including prostate carcinoma, non-small cell lung cancer, and colorectal cancer [12][13][14]. However, the biological role and corresponding regulatory mechanism of NR2F2-AS1 in cervical cancer remain unclear.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Accumulating literature has unveiled that NR2F2-AS1 is an oncogene in some cancers, including prostate carcinoma, non-small cell lung cancer, and colorectal cancer [12][13][14]. However, the biological role and corresponding regulatory mechanism of NR2F2-AS1 in cervical cancer remain unclear.…”
Section: Discussionmentioning
confidence: 99%
“…There is proof that as a member of lncRNAs, NR2F2 antisense RNA 1 (NR2F2-AS1) acts as a tumor promoter in some cancers. For instance, NR2F2-AS1 aggravates the progression of prostate carcinoma via CDK4 elevation [12]. NR2F2-AS1 sponges miR-320b to facilitate tumorigenesis through increasing BMI1 expression in non-small cell lung cancer [13].…”
Section: Introductionmentioning
confidence: 99%
“…AC093726.1 is associated with breast cancer ( 39 ), while AC093895.1 plays a pivotal role in the modulation of cancer-related pathways ( 40 ). NR2F2-AS1 is involved in the regulation of cell cycle progression, cell apoptosis, and cell proliferation during cancer ( 41 , 42 ). Patients harboring high-risk signatures had shortened overall survival, while patients harboring a low-risk signature had prolonged survival.…”
Section: Discussionmentioning
confidence: 99%
“…NR2F2-AS1 was found to promote cell proliferation in prostate carcinoma and lung cancer (29,30). Down-regulation of NR2F2-AS1 induced G 1 arrest of colorectal cancer cells and inhibited proliferation/induced apoptosis of nasopharyngeal carcinoma cells (29,30). Next and telomeric to NR2F2-AS1 is the NR2F2 gene, which is transcribed from centromere to telomere and in which alternate splicing results in multiple transcript variants (https://www.ncbi.nlm.nih.gov/gene/7026).…”
Section: Discussionmentioning
confidence: 99%